[Child osteoarticular infections: statements and perspectives]

Arch Pediatr. 2007 Oct:14 Suppl 2:S79-80. doi: 10.1016/s0929-693x(07)80038-8.
[Article in French]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Administration, Oral
  • Age Factors
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacokinetics
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Arthritis, Infectious / diagnosis
  • Arthritis, Infectious / drug therapy*
  • Arthritis, Infectious / microbiology
  • Bacterial Toxins
  • Child
  • Clinical Trials as Topic
  • Emergencies
  • Exotoxins
  • Humans
  • Infant
  • Infant, Newborn
  • Infusions, Intravenous
  • Injections, Intravenous
  • Kingella kingae / drug effects*
  • Leukocidins
  • Methicillin Resistance
  • Neisseriaceae Infections / diagnosis
  • Neisseriaceae Infections / drug therapy*
  • Osteomyelitis / diagnosis
  • Osteomyelitis / drug therapy*
  • Osteomyelitis / microbiology
  • Staphylococcal Infections / diagnosis
  • Staphylococcal Infections / drug therapy*
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / pathogenicity
  • Time Factors

Substances

  • Anti-Bacterial Agents
  • Bacterial Toxins
  • Exotoxins
  • Leukocidins
  • Panton-Valentine leukocidin